EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Alere's Enterprise Value is $4,003.79 Mil.
Alere's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 was $-54.14 Mil. Therefore, Alere's EV-to-EBIT for today is -73.96.
The historical rank and industry rank for Alere's EV-to-EBIT or its related term are showing as below:
During the past 13 years, the highest EV-to-EBIT of Alere was 639.40. The lowest was -676.00. And the median was 44.30.
ALRPRB.PFD's EV-to-EBIT is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 20.69 * Ranked among companies with meaningful EV-to-EBIT only.
The historical data trend for Alere's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Alere's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alere's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Alere's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Alere's EV-to-EBIT falls into.
Alere's current Enterprise Value is $4,003.79 Mil.
Alere's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alere (NYSE:ALRPRB.PFD) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Alere's Enterprise Value for the quarter that ended in Jun. 2017 was $0.00 Mil.
Alere's EBIT for the trailing twelve months (TTM) ended in Jun. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-54.14 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alere EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Alere's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Alere, Inc. develops rapid point-of-care diagnostic devices in cardiology, infectious disease, toxicology, diabetes, oncology, and women's health. North America accounts for the largest portion of the firm's revenue (55%), followed by Europe (19%), Asia-Pacific (14%), and the rest of the world (12%). Alere's headquarters are in Waltham, Massachusetts.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ALRPRB.PFD has been successfully added to your 